KR102133638B1 - Compositions for the prevention or treatment of oral diseases, including extracts of acer tegmentosum maxim and cinnamon - Google Patents

Abstract

The present invention relates to a composition for the prevention or treatment of oral diseases, which has an excellent effect in preventing or treating oral diseases by inhibiting the proliferation of various pathogens causing oral diseases by including extracts of sancheongmok and cinnamon as active ingredients. In the composition for preventing or treating oral diseases comprising an extract and cinnamon extract as an active ingredient, the oral diseases are selected from the group consisting of bad breath, dental caries, stomatitis, dental caries, periodontal disease, mucosal ulcers in the oral cavity, and dry mouth It is a technical point to be characterized by an oral disease.

Description

Compositions for the prevention or treatment of oral diseases, including Sanchungmok extract and cinnamon extract {Compositions for the prevention or treatment of oral diseases, including extracts of acer tegmentosum maxim and cinnamon}

The present invention relates to a composition for the prevention or treatment of oral diseases, including Sanchungmok extract and cinnamon extract, and more specifically, by suppressing the proliferation of various pathogens causing oral diseases by including the extract of Sancheongmok and cinnamon as an active ingredient. The present invention relates to a composition for preventing or treating oral diseases, which has an excellent effect in preventing or treating oral diseases.

One of the desires to live a healthier life, modern people not only want to have healthy teeth even over the age of 80, but also wash their mouth after meals to reduce bad breath, which is a hindrance to interpersonal relationships. Oral cleansing is performed for the purpose of preventing oral diseases such as dental caries, bad breath, periodontitis, and the like caused by damage to the oral cavity and teeth caused by changes in the diet of modern people.

Oral cleaning agents currently on the market use antibacterial and sodium benzoate, polyoxyethylene, polyoxypropylene polymer, cetylpyridinium chloride, sodium saccharin, sodium benzoate, etc. Preventive treatment. However, studies have been published that when swallowing these ingredients, they have side effects such as vomiting, nervous breakdown, coma, and diarrhea. When swallowed excessively, fatal damage is caused, and long-term use damages the oral cavity.

In particular, among the drugs used for the prevention and treatment of periodontitis, antibiotics such as penicillin, erythromycin, and tetracycline are effective for sterilization and growth inhibition, but have side effects such as causing the appearance of resistant bacteria, and antibacterial agents such as chlorhexidine are caries Although it has an effect of inhibiting formation, it is known to have strong toxicity.

Therefore, there is no side effect from natural products such as medicinal plants, and it is necessary to develop a natural substance that has a high antimicrobial activity selectively against harmful oral microorganisms and has a function of inhibiting substrate decomposition enzymes.

On the other hand, Sancheongmok is also called acer tegmentosum maxim, and it is a deciduous broad-leaved tree of the Maple family. It is a plant that is cultivated in the highlands and has traditionally used Sancheongmok bark as a medicinal material. There is no side effect of any constitution.

Cinnamon is a spice from several types of bark of Cinnamomum, and is used as a seasoning, spice, and herbal medicine. In one shot, cinnamon expresses its properties that it is very feverish, sweet, and very poisonous. In Donguibogam, cinnamon is introduced as a medicine that warms the inside, makes the blood vessels well, evens the liver or lungs, spreads all kinds of medicinal energy evenly, and does not show side effects, but can be miscarried.

As described above, various pharmacological effects of sancheongmok and cinnamon have been reported, but the effect of preventing or treating oral diseases of the mixture of the extracts of sancheongmok and cinnamon is still unknown, and there is no research on this. to be.

Therefore, the present inventors tried to develop a composition that has less side effects on the human body than chemical synthetic medicines and contains an active ingredient derived from natural products that can be easily manufactured and consumed, and which can exhibit a prevention or treatment effect of oral diseases. And it confirmed the use of the composition of the cinnamon extract mixed and completed the present invention.

KR 10-2016-0050108 A KR 10-1675443 B1

The present invention has been devised to solve the above problems, and has fewer side effects on the human body than chemical synthetic medicines, and includes an active ingredient derived from natural products that can be easily manufactured and consumed, and exhibits prevention or treatment effects of oral diseases. The technical solution is to provide a composition for the prevention or treatment of oral diseases, which includes an extract of San Cheongmok and cinnamon as an active ingredient.

On the other hand, the object of the present invention is not limited to the object mentioned above, other objects not mentioned will be clearly understood from the following description.

The present invention for solving the above technical problem is a composition for the prevention or treatment of oral diseases comprising the Sanchokmok extract and cinnamon extract as active ingredients, wherein the oral diseases are bad breath, tooth decay, stomatitis, dental caries, periodontal disease, intraoral It relates to a composition characterized in that it is an oral disease selected from the group consisting of mucosal ulcers and dry mouth.

The present invention for solving the above other technical problems in the food composition for preventing or improving oral diseases comprising sancheongmok extract and cinnamon extract as an active ingredient, the oral disease is bad breath, cavities, stomatitis, dental caries, periodontal disease, It relates to a composition characterized in that it is an oral disease selected from the group consisting of mucosal ulcers and dry mouth in the oral cavity.

By the means for solving the above problems, the composition for preventing or treating oral diseases of the present invention includes the Sancheongmok extract and the cinnamon extract as active ingredients, thereby preventing or treating oral diseases by inhibiting the growth of pathogens causing oral diseases. It has an excellent effect, has little side effects on the human body as a natural product, and has an effect that can be easily manufactured and consumed.

1 is a graph showing the results of an antioxidant activity evaluation experiment of a composition for the prevention or treatment of oral diseases, including sanchungmok extract and cinnamon extract according to an embodiment of the present invention.
Figure 2 is a photograph showing the results of an antioxidant activity evaluation experiment of a composition for the prevention or treatment of oral diseases, including San Chongmok extract and cinnamon extract according to an embodiment of the present invention.

Advantages and features of the present invention, and methods for achieving them will be clarified with reference to embodiments described below in detail together with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below, but will be implemented in various different forms, and only the embodiments allow the disclosure of the present invention to be complete, and have ordinary knowledge in the art to which the present invention pertains. It is provided to completely inform the person of the scope of the invention. And the terms used in this specification are for describing the embodiments, and are not intended to limit the present invention. In the present specification, the singular form includes the plural form unless otherwise specified in the phrase.

Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings. On the other hand, the illustration and detailed description of the configuration and the action and effect thereof, which can be easily recognized by those having ordinary knowledge in the relevant technical field, will be briefly omitted or omitted, and the details related to the present invention will be described in detail.

First, as used herein, the term'extract' has a meaning commonly used in the art as a crude extract, but also includes a fraction that broadly fractionates the extract. That is, the extracts of Sancheongmok and cinnamon used in the present invention include not only those obtained using an extraction solvent, but also those obtained by additionally applying a purification process. For example, a fraction obtained by passing the extract through an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatographs (made for separation according to size, charge, hydrophobicity or affinity), etc. Fractions obtained through various purification methods are also included in the extract of the present invention. In addition, the mountain blueberry extract and cinnamon extract used in the present invention may be prepared in powder form by additional processes such as distillation under reduced pressure and freeze drying or spray drying.

The term'comprising as an active ingredient' in the present specification means to include an amount sufficient to achieve the efficacy or activity of the following Sanchungmok extract and cinnamon extract. Since the present invention is a composition extracted from natural plant material, Sancheongmok and cinnamon, there is no side effect to the human body even when administered in excess, so the quantitative upper limit of the Sancheongmok extract and cinnamon extract contained in the composition of the present invention can be carried out by selecting within an appropriate range by those skilled in the art. have.

As used herein, the term'prevention' refers to all actions that inhibit oral disease or delay progression by administration of the composition of the present invention.

In addition, the term'administration' in the present specification means providing a predetermined composition of the present invention to an individual in any suitable way.

The composition for preventing or treating oral diseases according to an embodiment of the present invention includes an extract of San Cheongmok and cinnamon as an active ingredient. And the oral disease is characterized in that it is selected from the group consisting of bad breath, dental caries, stomatitis, dental caries, periodontal disease, mucosal ulcers in the oral cavity and dry mouth. Preferably, the oral disease may mean tooth decay and periodontal disease.

Periodontal disease (Periodontal Disease) is a chronic, infectious disease (inflammatory disease accompanied by alveolar bone absorption) in which tissue destruction occurs due to a host reaction due to the deposition of bacterial plaque in the periodontal tissue. The cause of periodontal disease cannot be explained by one single thing, and it can be regarded as a chronic disease usually caused by complex causes.

Several species are known as pathogenic microorganisms that cause dental caries and periodontal disease in the oral cavity, but Streptococcus mutans and Porphyromonas gingivalis are the main pathogens causing caries and periodontitis. It is known as [Liliemark WF, Crit. Rev. Oral Bio. Med., 7:180??198, 1996]. Pathogenic microorganisms in the oral cavity secrete an enzyme called glucosyltransferase (GTase) from the surface or outside the cell, producing glucose and fructose using sucrose as a substrate in food, At the same time, insoluble glucan, a polymer of glucose, is formed on the tooth surface. When other microorganisms are attached to the tooth surface by forming the glucan, they form a bacterial membrane, that is, a dental plaque. The lactic acid bacteria proliferate in the plaque produced lactic acid to paroxetine lactose as a carbon source, and the adherent glucans lactic acid is collected and concentrated on, thus the concentrated high-concentration acid is tooth and of the calcium phosphate composition of the dental Ca unloaded melt ^{2 +} Tooth decay is caused by dissolving the enamel, the outer membrane of [Sigmund, SS, et al., J. Periodontol., 63:322-331, 1992].

Further, pathogenic microorganisms within the oral cavity is to form a coating of bacterial plaque on the tooth surface, whereby the lactic acid produced from lactic acid bacteria proliferating in a high concentration plaque accumulation roll is lost in teeth is calcium ions (Ca ^{2 +).} Due to this, cavities are induced along with the dissolution of the outer enamel of the tooth, and toxic substances from the plaque penetrate into the crevice between the teeth and gums, causing intracellular inflammatory reactions, resulting in periodontal diseases such as gingivitis and periodontitis.

Bacterial antigenic substances represented by endotoxins or lipopolysaccharides (LPS) from the plague penetrate into the gingival tissue, and neutrophils and macrophages induced by it are activated by phagocytosis from the bacterial antigenic substances from the plague. It releases enzymes such as hydrolase (collagenase), gelatin hydrolase (gelatinase), elastin hydrolase (elastase), and Cathepsin G out of the cell. These enzymes work cooperatively with each other to break down organic components of the gingival tissue, such as collagen and proteoglycans.

On the other hand, neutrophils or macrophages release inflammatory cytokines and stimulate surrounding gingival fibroblasts to promote the production of matrix metalloproteinase (MMP), but inhibitors of these enzymes, TIMF (tissue) Inhibitor of metalloprotease production is almost unchanged or rather inhibited, causing the substrate (collagen) to degrade. Thus, gingival tissue softening and disintegration, persistent bleeding, and the like appear. As a major supplier of enzymes involved in collagen degradation, periodontal disease-causing bacteria such as porphylomonase gingivalis, which are distributed in plaques, can be cited. These bacteria secrete collagen hydrolases and trypsin-like proteolytic enzymes, which break down collagen and connective tissue such as fibronectin.

In addition, bacterial enzymes display MMP activity by activating inactive precursors or degrading TIMF. Proteoglycans in the periodontal tissue can be decomposed by various bacterial enzymes, and macromolecules such as collagen, proteoglycans, and hyalulonic acid may be destroyed by normal cell metabolites such as free radicals.

According to an embodiment of the present invention, the extract of San Cheongmok and cinnamon extract confirmed that the growth inhibitory activity of Streptococcus mutans, Porphyromonas ginivalis, which are the main pathogens of periodontal disease, was confirmed. And cinnamon extract is believed to be effective in preventing or treating oral diseases by inhibiting the proliferation of pathogens causing oral diseases.

In addition, the extracts of mountain blueberry and cinnamon used in the composition of the present invention include water, distilled water, methanol, ethanol, propanol, isopropanol, butanol, acetone, ether, ethyl acetate, methylene chloride, n-hexane, hydrochloric acid, acetic acid, formic acid, and diethyl. It is an extract extracted using one or more solvents selected from the group consisting of ether and cyclohexane. Preferably, it may be obtained by treating acid blue wood and cinnamon in a solvent that is water, ethanol, or a mixture thereof.

Sancheongmok extract and cinnamon extract contained in the composition of the present invention can be used in the form of a powder or extract, and the amount and ratio can be variously adjusted according to the amount of sancheongmok and cinnamon used in the extraction, the degree of extraction concentration and use. . For example, the composition of the present invention may be used by mixing the mountain cedar tree extract and cinnamon extract in a ratio of 1:1, 1.5:0.5 or 0.5:1.5.

The composition according to an embodiment of the present invention is characterized by having any one or more formulations selected from the group consisting of toothpaste, gum, mouthwash, mouthwash, mouthwash, mouthwash, and mouth patch. do.

The toothpaste of the present invention includes a composition selected from the group consisting of abrasives, caking agents, moisturizers, active ingredients, blowing agents, sweeteners, flavoring agents.

As the abrasive, aluminum hydroxide, silicic acid anhydride, aluminum silicate, dibasic calcium phosphate, dihydrate and anhydride, tricalcium phosphate, calcium carbonate, calcium pyrophosphate, insoluble sodium metaphosphate, tribasic magnesium phosphate, magnesium carbonate, calcium sulfate, Polymethyl acrylate, other synthetic resins or the like may be used in combination of one or two or more in an amount of about 10-90% of the total composition.

As a caking additive, synthetic polymers such as garraginine, various thickening cellulose derivatives, xanthan gum, and tragacanth gum, polyvinyl alcohol, sodium polyacrylate, polyacrylic acid/maleic acid copolymer, and carboxyvinyl polymer It can be used by selecting one or two or more types of organic caking agents such as derivatives and inorganic caking agents such as silica and laponite.

On the other hand, in the composition according to an embodiment of the present invention, menthol (Mentol), enetol (Anetol), eugenol (Eugenol), limonene (Limonene), oscimen (Ocimene), n- dodecyl alcohol (n-Dodecy) Alcohol, Citronenol, Alpha-Terpineol, Methyl salycilate, Methyl Acetate, Citronelyl Acetate, Cineol, Linalool, Ethyl Linalool, Vanillin, Thymol, Speamint oil, Sage oil, Rosemary oil, Cinnamon oil, etc. The antibiotics may be used alone or in combination in an amount of 0.1-10%, preferably 0.5-5% of the total composition.

In addition, sweeteners such as sodium saccharin, stevioside, aspartame, and D-Xylose can be used in combination.

The oral compositions of the present invention include cationic fungicides such as triclosan, chlorohexidine, benzethonium chloride, benzalkonium chloride, cetylpyridinium chloride, and alkali metal monofluorophosphates such as sodium monofluorophosphate and potassium monofluorophosphate. And sodium fluoride, fluoride such as stannous fluoride, tranexamic acid, epsilon amino capronic acid, aluminum chlorohydroxy allantoin, dihydrocholestanol, clitilic acid, glycero phosphate, sodium chloride, water-soluble inorganic phosphoric acid compounds, Ascorbic acid (sodium), dl-a-tocopherol acetate, xylitol, pyridoxine hydrochloride, polyvinyl pyrrolidone, etc. can be used by selecting one or two or more of various effective ingredients.

In addition, anionic surfactants, nonionic surfactants and/or amphoteric surfactants may be used as surfactants used as foaming components in the oral composition of the present invention. Here, as the anionic surfactant, sodium alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate, sodium N-Lauroyl sarcosinate, sodium N-miristyl sarcosinate, and the like, sodium N-miristyl sarcosinate, etc. Sodium N-acyl sarcosinate can be used, and non-ionic surfactants are sugar-derived fatty acid esters such as sugar fatty acid esters, maltose fatty acid esters, lactose fatty acid esters, poly Oxyethylene cured castor oil, polyoxyethylene higher alcohol ether, polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polypropylene fatty acid ester, and the like can be used. As the cationic surfactant, N-alkyl diaminoethylglycine such as N-lauryl diaminoethylglycine, N-myristyl diaminoethylglycine, N-alkyl-N-carboxy methyl ammonium betaine, 2-alkyl-1 -Hydroxy ethyl imidazoline betaine sodium, etc. can be used. In this case, anionic surfactant is mainly used as the foaming component, and as a representative example, sodium alkylsulfate such as sodium lauryl sulfate is most widely used. In addition, these surfactants may be used alone or in combination of two or more, and the blending amount may be usually 0.01-0.5% of the total composition, more preferably 0.05-0.3%.

On the other hand, when preparing the pharmaceutical composition of the present invention, (a) a pharmaceutically effective amount of the above-described mountain cheongmok extract and cinnamon extract of the present invention; And (b) a pharmaceutically acceptable carrier. In another embodiment, (a) a pharmaceutically effective amount of the above-described mountain cedar tree extract and cinnamon extract of the present invention; And (b) a pharmaceutically acceptable carrier. The term'pharmaceutical effective amount' means an amount sufficient to achieve the efficacy or activity of the above-described Sanchungmok extract and cinnamon extract.

In this case, the pharmaceutically acceptable carrier is commonly used in formulations such as lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, Polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methyl hydroxybenzoate, propylhydrocybenzoate, talc, magnesium stearate and mineral oil, and the like, but is not limited thereto.

The pharmaceutical composition of the present invention may further include a lubricant, a wetting agent, a sweetener, a flavoring agent, an emulsifying agent, a suspending agent, a preservative, etc. in addition to the above components. Suitable pharmaceutically acceptable carriers and formulations are described in detail in Remington's Pharmaceutical Sciences (19th ed., 1995).

In addition, the pharmaceutical composition of the present invention can be administered orally or parenterally. At this time, a suitable dosage of the pharmaceutical composition of the present invention is variously prescribed by factors such as the formulation method, the administration method, the patient's age, weight, sex, morbidity, food, administration time, administration route, excretion rate, and response sensitivity. Can be. The general dosage of the pharmaceutical composition of the present invention is within the range of 0.001 to 100 mg/kg on an adult basis.

Although not particularly limited, the pharmaceutical composition of the present invention is formulated using a pharmaceutically acceptable carrier and/or excipient according to a method that can be easily carried out by those skilled in the art to which the present invention pertains. By doing so, it can be produced in a unit dose form or can be produced by incorporating it into a multi-dose container. In this case, the formulation may be in the form of a solution, suspension, syrup or emulsion in an oil or aqueous medium, or may be in the form of ex, powder, granule, tablet or capsule, and may further include a dispersant or a safety agent.

In addition, as another embodiment of the present invention, the present invention relates to a food composition for prevention or improvement of oral diseases comprising an extract of cinnamon tree and cinnamon as an active ingredient. At this time, the oral disease is characterized in that it is selected from the group consisting of bad breath, dental caries, stomatitis, dental caries, periodontal disease, mucosal ulcers in the oral cavity and dry mouth. Preferably, the oral disease may mean tooth decay and periodontal disease.

The food composition for prevention or improvement of oral diseases, such as the pharmaceutical composition for prevention or treatment of oral diseases described above, includes an extract of San Cheongmok and cinnamon as an active ingredient. The description of the extract is the same or similar to that described in the pharmaceutical composition.

The food composition means a natural product or a processed product containing one or more nutrients, and preferably means a state that can be directly eaten after a certain processing process, and in a general sense, is a health functional food. , Beverages, food additives and beverage additives.

Specifically, the food composition may include, as an active ingredient, an extract of cinnamon tree and cinnamon, as well as ingredients that are commonly added during food preparation. For example, it may include proteins, carbohydrates, fats, nutrients, flavoring agents and flavoring agents. Examples of the carbohydrates described above include monosaccharides, such as glucose, fructose, and the like; Disaccharides such as maltose, sucrose, oligosaccharides, etc.; And polysaccharides, for example, conventional sugars such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents, natural flavoring agents (tauumatin, stevia extract (eg, rebaudioside A, glycyrrhizine, etc.)) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used.

In addition, when the food composition of the present invention is prepared as a drink agent, citric acid, liquid fructose, sugar, glucose, acetic acid, malic acid, juice, worm extract, jujube extract, licorice extract, etc. Can be included.

Hereinafter, the present invention will be described in detail by way of examples, but the scope of the present invention is not limited to the following examples.

< Example >

Mountain tree Preparation of extract and cinnamon extract

After crushing each of the mountain blueberry and cinnamon using a grinder, freeze-dried at -20°C, 100 g of dried sample and 1 L of 80% ethanol were added to the mixer, and extracted at room temperature for 4 hours. After extraction, the residue was filtered using filter paper, and only the liquid component was filtered through a flask.

The filtered liquid component was immersed in a water bath at 65°C to prepare a pure Sanchokmok extract and cinnamon extract, and a composition for preventing or treating oral diseases by mixing the Sanchokmok extract and cinnamon extract in a ratio of 1:1 (hereinafter, "Sancheongmok") /"Cinnamon Extract Mixture").

< Experimental Example >

Experimental Example 1: Antioxidant activity evaluation experiment

In this experiment, a free radical was removed to evaluate antioxidant activity, and a DPPH (1,1-diphenyl-2-picryl hydrazyl) radical scavenging activity experiment was performed.

This experiment uses the property that the hydrazyl of DPPH contains unstable nitrogen atoms and can easily accept hydrogen atoms, so it reacts with antioxidant substances and loses its inherent coloration by accepting hydrogen atoms.

Accordingly, the degree of radical reduction using a DPPH was measured with a spectrophotometer to indirectly measure the antioxidant activity of the sample, and it was observed that the radical was reduced to antioxidant and lost its own purple color and turned yellow.

Specifically, a DPPH solution was prepared by mixing 0.08 g of DPPH and 1 L of ethanol in a dark room where light was blocked, and the prepared DPPH solution was stored and used at -20°C.

Then, samples for antioxidant activity evaluation were prepared by concentration. 1 ml of a solution prepared from 6 concentrations of 1000 μg/ml, 500 μg/ml, 250 μg/ml, 125 μg/ml, 62.5 μg/ml, and 31.25 μg/ml of the Sancheongmok/Cinnamon extract mixture (control: 99.5% ethanol) After adding 1 ml of the DPPH solution, the mixture was shaken for 10 seconds using a Vortex mixer, and then incubated at 37° C. for 30 minutes to prepare samples according to concentration.

As a positive control drug, L-ascorbic acid was prepared at 6 concentrations as in the sample, and then 1 ml of DPPH solution was added to prepare a control solution.

After that, the absorbance at 517 nm was measured using an x-Mark micro spectrophotometer reader, and the antioxidant activity of the Sancheongmok/cinnamon extract mixture and the positive control drug is called abs(control). Absorbance of the Sanchokmok/cinnamon extract mixture was taken as abs(sample), and the activity inhibition rate of DPPH was obtained according to the following equation, and this is shown in FIG. 1.

Inhibition (%) = abs(control)-abs(sample) / abs(control) * 100

1 is a graph showing the results of an antioxidant activity evaluation experiment of a composition for the prevention or treatment of oral diseases, including sanchungmok extract and cinnamon extract according to an embodiment of the present invention.

Referring to FIG. 1, the antioxidant activity of the positive control drug L-ascorbic acid is 92% at a concentration of 1000 μg/ml, 90% at 500 μg/ml, 90% at 250 μg/ml, 125 89% at µg/ml, 82% at 62.5µg/ml, and 84% at 31.25µg/ml.

And the antioxidant activity of the mountain cedar/cinnamon extract mixture according to the embodiment is 83% at a concentration of 1000 µg/ml, 77% at 500 µg/ml, 63% at 250 µg/ml, and 125 µg/ml per day. When it was 49%, when it was 62.5 µg/ml, it was 32%, and when it was 31.25 µg/ml, it was not measured.

Figure 2 is a photograph showing the results of the antioxidant activity evaluation of the composition for the prevention or treatment of oral diseases, including San Chongmok extract and cinnamon extract according to an embodiment of the present invention, (a) is a concentration 1000㎍ / ml, ( b) 500 µg/ml, (c) 250 µg/ml, (d) 125 µg/ml, (e) 62.5 µg/ml, and (f) 31.25 µg/ml of mountain cedar/cinnamon extract mixture It is the result of the anti-oxidation activity evaluation experiment.

Referring to FIG. 2, it can be seen that DPPH reacts with the mixture to lose the intrinsic purple color and turns yellow as the concentration of the mountain blueberry/cinnamon extract mixture increases.

That is, as shown in the experimental results of the DPPH radical scavenging activity of Experimental Example 1, the Sancheongmok/Cinnamon extract mixture exhibited concentration-dependent antioxidant power, and showed an activity of about 80% at 500 µg/ml, and the composition of the present invention had an antioxidant effect. It can be seen that there is.

Experimental Example 2: Real time Polymerase chain reaction (Real-time polymerase chain reaction, RT-PCR) Assay

In this experimental example, to evaluate the antimicrobial activity against pathogens in oral diseases, the effect of the mixture of San Cheongmok/cinnamon extract on gene expression in oral disease pathogens was analyzed through a real-time polymerase chain reaction. At this time, as a pathogen for oral diseases, Streptococcus mutans and Porphyromonas ginivalis provided by the Korea Research Institute of Bioscience and Biotechnology were used, and RNA of the pathogen was isolated to examine the expression change of genes (sodA and gtfB) in each pathogen at the transcription level.

Specifically, each strain culture solution was inoculated into a liquid medium, incubated at 37°C for 24 hours, and then 10 ml of the strain culture solution was inoculated again into a liquid medium, and cultured until absorbance of 0.4 at a wavelength of 600 nm. Thereafter, the Sanchok/Cinnamon extract mixture was added dropwise to a liquid medium and cultured for 2 hours. The Sanchok/Cinnamon extract mixture was 0 mg/ml or 0.05 mg/ml, which was a concentration below the MIC (Minimal inhibitory concentration). Treatment at concentrations of 0.1 mg/ml, 0.2 mg/ml and 0.5 mg/ml.

Then, total RNA of each strain was extracted by adding Trizol reagent (Gibco-BRL) to the liquid medium, and cDNA was synthesized using reverse transcriptase reaction (Gibco-BRL).

At this time, DNA analysis was performed using ABI-Prism 7000, and real-time polymerization chain reaction was performed through qPCR SYBR Green Mixes (Applied Bio system Inc., Foster City, CA, USA), and PCR reaction conditions were 15 at 95°C. After initial denatration for a second, annealing and extension were performed at 60°C for 1 minute.

In addition, the expression level of all genes was normalized using an internal standard, and the analysis was performed by duplicating at least two independent RNA samples.

Table 1 below shows the gene sequence of oral disease pathogens.

Amplicon Size (bp) Target Universal for bacteria prbac1 5′-ACT ACG TGC CAG CAG CC 296-300 16S rRNA prbac2 5′-GGA CTA CCA GGG TAT CTA ATC C S. mutans GTFB-F 5′-ACT ACA CTT TCG GGT GGC TTG G 517 gtfB GTFB-R 5′-CAG TAT AAG CGC CAG TTT CAT C P. gingivalis sod-F 5′-CCT ATG TGG ACA ACC TCA AT 517 sodA sod-R 5′-GGC TTC CTT ATG TAT TGG TG

After treating the cultivar/cinnamon extract mixture with a concentration of 0.5 mg/ml or less in the MIC, the result of observing the expression of the virulence factor of the strain using the Real-time PCR is shown in the following table. It is shown in 2.

Strain
(gene) Mountain tree / cinnamon
Concentration of extraction mixture (mg/mL) Relative amount ^*
S. mutans
(gtfB )
0 One 0.05 One 0.1 0.91 0.2 0.49 0.5 0.46
P. gingivalis
(sodA) 0 One 0.05 One 0.1 One 0.2 0.9 0.5 0.88

Relative amount: The difference in expression level was obtained by applying the expression levels of gtfB and sodA compared to 16S rRNA of each strain, respectively, to obtain a relative quantitative value.

Referring to Table 2, the gene gtfB of the strain in the S. mutans strain culture medium has a concentration of 0 mg/ml of the mountain cedar/cinnamon extract mixture, that is, expression is not inhibited when the mixture is not added, and this is the same even when 0.05 mg/ml. Appeared. And the gene of the strain was 0.91 when the concentration of the mixture was 0.1 mg/ml, 0.49 when it was 0.2 mg/ml, and 0.46 when it was 0.5 mg/ml.

In addition, in the culture medium of P. gingivalis strain, the virulence factor sodA of the strain was 0 mg/ml in the concentration of the mountain blueberry/cinnamon extract mixture, that is, the expression was not suppressed when the mixture was not added, and when it was 0.05 mg/ml and 0.1 mg/ml day It appeared the same when. And the virulence factor of the strain was 0.9 when the concentration of the mixture was 0.2 mg/ml, and 0.88 was expressed when 0.5 mg/ml.

That is, as shown in the results of real-time PCR analysis, the mountain blueberry/cinnamon extract mixture inhibited the expression of the gene gtfB synthesizing GTFase B of S. mutans in a concentration-dependent manner, and the gene sodA synthesizing the virulence factor of P. gingivalis Suppressed expression. It can be seen that the composition of the present invention has excellent antibacterial activity for effectively inhibiting gene expression in oral disease pathogens by showing about 50% inhibitory activity at 0.2 mg/ml.

As described above, in the present embodiment, the antioxidant activity was analyzed by the DPPH radical scavenging activity test for the mountain cedar/cinnamon extract mixture, and the effect of preventing or treating oral diseases of the mountain cedar/cinnamon extract mixture was evaluated through a real-time PCR analysis experiment. Did. As a result, the Sancheongmok/Cinnamon extract mixture showed an antioxidant activity of about 80% at 500µg/ml, and an inhibitory activity of gene expression in oral disease pathogens at 0.2mg/ml, showing excellent antibacterial activity. Could.

Therefore, from the results of these examples, the Sancheongmok and cinnamon extracts of the present invention can suppress the growth and proliferation of various pathogens causing oral diseases, thereby controlling the inflammatory response, and by having an antioxidant function, it is excellent in preventing or treating oral diseases. It is judged that there is.

The foregoing has outlined rather broadly the features and technical advantages of the present invention in order to better understand the claims of the invention that follows. Those of ordinary skill in the art to which the present invention pertains will appreciate that the present invention may be implemented in other specific forms without changing its technical spirit or essential features. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of the present invention is indicated by the following claims rather than the above detailed description, and all modifications or variations derived from the claims and equivalent concepts should be construed as being included in the scope of the present invention.

Claims (5)

In the composition for the prevention or treatment of oral diseases comprising Sanchokmok extract and cinnamon extract as an active ingredient,
The weight ratio of the Sancheongmok extract and cinnamon extract is 1:1, 3:1 or 1:3,
The oral disease is a caries or periodontal disease caused by Streptococcus mutans or Porphyromonas gingivalis,
A composition characterized by inhibiting the gene expression of said Streptococcus mutans and Porphyromonas gingivalis. According to claim 1,
The sanchokmok extract and cinnamon extract are a group consisting of water, distilled water, methanol, ethanol, propanol, isopropanol, butanol, acetone, ether, ethyl acetate, methylene chloride, n-hexane, hydrochloric acid, acetic acid, formic acid, diethyl ether and cyclohexane. A composition characterized in that it is extracted using at least one solvent selected from. According to claim 1,
The sancheongmok extract and cinnamon extract is a composition characterized in that extracted with water, ethanol or a mixture thereof. According to claim 1,
The composition is characterized in that it has any one or more formulations selected from the group consisting of toothpaste, gum, mouthwash, mouthwash, mouthwash, mouthwash, and mouth patch. In the food composition for the prevention or improvement of oral diseases comprising Sanchokmok extract and cinnamon extract as an active ingredient,
The weight ratio of the Sancheongmok extract and cinnamon extract is 1:1, 3:1 or 1:3,
The oral disease is a caries or periodontal disease caused by Streptococcus mutans or Porphyromonas gingivalis,
A composition characterized by inhibiting the gene expression of said Streptococcus mutans and Porphyromonas gingivalis.

Images